Colon cancer, which is strongly linked to IBD‐associated chronic inflammation, is a significant risk factor for colon cancer, and HIF‐2α deletion reduced the number of colon tumors and tumor load and increased apoptosis of tumor cells. This evidence concerns the gene EPAS1 and neoplasm.